AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Top 37%
#1892 out of 5192 analysts
Average Return
+13.16%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viridian Therapeutics IncVRDN | +73.93% | $16.53 | $28.75 | 2025-08-06 - 2026-02-12 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +47.67% | $8.81 | $13.01 | 2025-06-16 - 2026-02-12 | Buy |
Eyepoint Pharmaceuticals IncEYPT | +17.42% | $11.08 | $13.01 | 2025-11-05 - 2026-02-12 | Buy |
United Therapeutics CorpUTHR | +10.05% | $432.66 | $476.13 | 2025-09-25 - 2026-02-12 | Buy |
United Therapeutics CorpUTHR | +4.98% | $453.53 | $476.13 | 2025-10-29 - 2026-02-12 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | 1 | Buy | $16.00 | +117.39% | Maintains | 3 months ago |
4d Molecular Therapeutics IncFDMT | 2 | Buy | $32.00 | +241.88% | Maintains | 3 months ago |
Viridian Therapeutics IncVRDN | 2 | Buy | $45.00 | +56.52% | Maintains | 3 months ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Buy | $39.00 | +199.77% | Maintains | 3 months ago |
United Therapeutics CorpUTHR | 2 | Buy | $587.00 | +23.29% | Maintains | 3 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 1 | Hold | $19.00 | -13.83% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.